E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Analysis of 16S rRNA gene sequences and circulating cell-free DNA from plasma of chronic fatigue syndrome and non-fatigued subjects.
Vernon, Suzanne D, Shukla, Sanjay K, Conradt, Jennifer et al. · BMC microbiology · 2002 · DOI
Quick Summary
Researchers tested whether bacteria in the bloodstream might be linked to ME/CFS by analyzing blood samples from people with ME/CFS and healthy controls. They found that healthy people had more detectable bacterial DNA in their blood than ME/CFS patients did, and no unique or unusual bacteria were found in either group. This suggests that a specific bacterial infection is unlikely to be a primary cause of ME/CFS.
Why It Matters
This study directly addressed whether a hidden bacterial infection might explain ME/CFS symptoms. The results help rule out a straightforward bacterial infection model, redirecting research toward understanding why ME/CFS patients show different plasma DNA patterns and encouraging investigation of other potential mechanisms.
Observed Findings
- Bacterial 16S rDNA sequences were detected in 14% (4/34) of CFS subjects versus 32% (17/55) of non-fatigued controls (p=0.03).
- Non-fatigued subjects had higher average plasma DNA concentrations (151 ng) than CFS subjects (91 ng), though not statistically significant.
- All but one subject with detectable bacterial DNA had five or more unique bacterial sequences present.
- Bacterial sequences were diverse and non-specific in both CFS and control groups, with no unique or previously uncharacterized sequences identified.
Inferred Conclusions
- A single, predominant bacterial pathogen does not appear to be associated with CFS.
- The diverse, non-specific nature of bacterial DNA in plasma of both groups suggests contamination or normal background rather than targeted infection.
- CFS subjects show lower rates of detectable circulating bacterial DNA compared to healthy controls, contrary to an active systemic bacterial infection hypothesis.
Remaining Questions
- Why do CFS subjects have lower detectable bacterial DNA in plasma compared to controls, and what does this difference mean mechanistically?
- Could altered host immune responses or microbial dysbiosis in tissues (rather than bloodborne pathogens) contribute to ME/CFS?
What This Study Does Not Prove
This study does not prove bacteria are completely uninvolved in ME/CFS—it only shows that a single dominant bacterial pathogen in the bloodstream is unlikely. The cross-sectional design cannot establish causation, and the diverse bacterial sequences detected may still reflect disease-related changes rather than causal agents. The absence of a 'unique' pathogen does not exclude roles for altered microbial communities or dysbiosis.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1186/1471-2180-2-39
- PMID
- 12498618
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →